Caris Life Sciences, Inc. (CAI) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 216.17M | 292.89M | 216.83M | 181.4M | 120.92M | 100.83M | 85.69M | 80.8M | 64.32M | 79.05M | 75.72M | 105.02M |
| Revenue Growth % | 78.78% | - | - | - | - | 27.55% | 13.17% | -23.06% | -35.79% | -26.51% | -28.27% | -5.48% |
| Cost of Goods Sold | 74.83M | 71.97M | 69.33M | 67.71M | 63.85M | 46.74M | 42.83M | 42.21M | 23.53M | 30.43M | 28.85M | 53.86M |
| COGS % of Revenue | 34.61% | 24.57% | 31.97% | 37.33% | 52.81% | 46.36% | 49.98% | 52.24% | 36.59% | 38.49% | 38.09% | 51.29% |
| Gross Profit | 141.35M | 220.91M | 147.51M | 113.69M | 57.06M | 54.09M | 42.87M | 38.59M | 40.79M | 48.62M | 46.88M | 51.16M |
| Gross Margin % | 65.39% | 75.43% | 68.03% | 62.67% | 47.19% | 53.64% | 50.02% | 47.76% | 63.41% | 61.51% | 61.91% | 48.71% |
| Gross Profit Growth % | 147.71% | - | - | - | - | 11.24% | -8.56% | -24.57% | -14.33% | -6.1% | -7.77% | -6.65% |
| Operating Expenses | 136.07M | 132.5M | 114.86M | 95.7M | 115.02M | 12.29M | 10.17M | 7.74M | 4.72M | 13.07M | 13.86M | 17.57M |
| OpEx % of Revenue | 62.94% | 45.24% | 52.97% | 52.75% | 95.12% | 12.19% | 11.87% | 9.58% | 7.34% | 16.54% | 18.31% | 16.73% |
| Selling, General & Admin | 104.75M | 100.66M | 93.24M | 106.63M | 91.95M | 12.29M | 10.17M | 7.74M | 4.72M | 13.07M | 13.86M | 17.57M |
| SG&A % of Revenue | 48.46% | 34.37% | 43% | 58.78% | 76.04% | 12.19% | 11.87% | 9.58% | 7.34% | 16.54% | 18.31% | 16.73% |
| Research & Development | 5.37M | 31.84M | 21.62M | 25.05M | 23.07M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | 2.49% | 10.87% | 9.97% | 13.81% | 19.08% | - | - | - | - | - | - | - |
| Other Operating Expenses | 1000K | 0 | 0 | -1000K | 1K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 5.28M | 88.41M | 32.64M | 17.99M | -57.95M | 66.44M | 50.84M | 48.76M | 36.06M | 35.55M | 33.02M | 33.59M |
| Operating Margin % | 2.44% | 30.19% | 15.05% | 9.92% | -47.93% | 65.9% | 59.33% | 60.35% | 56.07% | 44.97% | 43.6% | 31.98% |
| Operating Income Growth % | 109.11% | - | - | - | - | 86.9% | 53.98% | 45.19% | 28.27% | 3.32% | -4.1% | -4.83% |
| EBITDA | 10.35M | 92.7M | 37.51M | 24.4M | -50.91M | 99.33M | 80.31M | 77.53M | 59.8M | 66.17M | 61.6M | 61.3M |
| EBITDA Margin % | 4.79% | 31.65% | 17.3% | 13.45% | -42.1% | 98.51% | 93.72% | 95.95% | 92.97% | 83.7% | 81.34% | 58.37% |
| EBITDA Growth % | 120.33% | - | - | - | - | 50.11% | 30.38% | 26.47% | 9.02% | 4.01% | 2.38% | -9.22% |
| D&A (Non-Cash Add-back) | 5.07M | 4.29M | 4.87M | 6.41M | 7.04M | 32.88M | 29.48M | 28.77M | 23.73M | 30.62M | 28.58M | 27.72M |
| EBIT | 5.28M | 93.31M | 37.83M | -52.58M | -89.8M | 0 | 50.91M | 48.35M | 57.54M | 34.94M | 34.66M | 15.79M |
| Net Interest Income | -5.97M | -4.34M | -6.15M | -17.59M | -12.28M | 0 | -11.11M | -11.17M | -6.96M | -16.63M | -17.59M | -20.38M |
| Interest Income | 6.83M | 7.01M | 7.36M | 1.62M | 503K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 12.81M | 11.36M | 13.51M | 19.21M | 12.78M | 0 | 11.11M | 11.17M | 6.96M | 16.63M | 17.59M | 20.38M |
| Other Income/Expense | -5.93M | -6.45M | -8.32M | -89.78M | -44.63M | -11.61M | -11.04M | -11.58M | -19.43M | -18.76M | -32.53M | -38.17M |
| Pretax Income | -644K | 81.96M | 24.32M | -71.79M | -102.58M | 54.83M | 39.8M | 37.18M | 16.64M | 16.79M | 487K | -4.59M |
| Pretax Margin % | -0.3% | 27.98% | 11.22% | -39.58% | -84.84% | 54.38% | 46.44% | 46.02% | 25.87% | 21.24% | 0.64% | -4.37% |
| Income Tax | -134K | 0 | 0 | 0 | 0 | 3.68M | 1.86M | 2.5M | 2.39M | 1.35M | 1.11M | -3.26M |
| Effective Tax Rate % | 20.81% | 0% | 0% | 0% | 0% | 6.71% | 4.66% | 6.73% | 14.39% | 8.03% | 228.54% | 71.02% |
| Net Income | -510K | 81.96M | 24.32M | -71.79M | -102.58M | 51.16M | 37.94M | 35.74M | 14.25M | 15.44M | -626K | -1.33M |
| Net Margin % | -0.24% | 27.98% | 11.22% | -39.58% | -84.84% | 50.74% | 44.28% | 44.23% | 22.15% | 19.54% | -0.83% | -1.27% |
| Net Income Growth % | 99.5% | - | - | - | - | 231.25% | 6161.18% | 2787.22% | 81.5% | 425.32% | -106.71% | -107.16% |
| Net Income (Continuing) | -510K | 81.96M | 24.32M | -71.79M | -102.58M | 51.16M | 37.94M | 35.74M | 14.25M | 15.44M | -626K | -1.33M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.00 | 0.28 | 0.08 | -1.87 | -0.40 | 2.92 | 2.17 | 2.04 | 0.79 | 0.87 | -0.04 | -0.08 |
| EPS Growth % | 99.55% | - | - | - | - | 235.63% | 6195.51% | 2773.66% | 75.56% | 422.22% | -106.85% | -107.79% |
| EPS (Basic) | -0.00 | 0.29 | 0.09 | -1.93 | -0.40 | 2.95 | 2.20 | 2.07 | 0.80 | 0.88 | -0.04 | -0.08 |
| Diluted Shares Outstanding | 282.56M | 1.67B | 297.21M | 276M | 254.79M | 17.53M | 17.48M | 17.52M | 17.95M | 17.71M | 17.6M | 17.43M |
| Basic Shares Outstanding | 282.56M | 1.67B | 282.1M | 268.44M | 254.79M | 17.34M | 17.28M | 17.27M | 17.71M | 17.57M | 17.47M | 17.43M |
| Dividend Payout Ratio | - | - | - | - | - | 14.49% | 19.52% | 20.7% | 46.74% | 42.96% | - | - |